WRBY
Medical Instruments & Supplies · Healthcare
CEO, Chief Accounting Officer, CFO, Board Member
2009-01-01–present
Chief Accounting Officer
Warby Parker Inc. (WRBY)Board Member
Warby Parker Inc. (WRBY)Equibles does not estimate personal net worth.
Get an email with a short summary when Warby Parker Inc. publishes a filing, an earnings call transcript or a press release.
Get WRBY alertsDave Gilboa is recorded as Chief Accounting Officer and CFO at Warby Parker Inc. (WRBY) since October 1, 2025, Board Member at Warby Parker Inc. (WRBY) since January 1, 2009 and CEO at Warby Parker Inc. (WRBY). The newest filing on record that lists Dave Gilboa as CEO and Board Member at Warby Parker Inc. (WRBY) is dated April 28, 2026. The proxy statement of Warby Parker Inc. reports total compensation of $8,997,680 for Dave Gilboa in fiscal 2025, including a base salary of $575,000. Disclosed compensation is on record for 6 fiscal years. Dave Gilboa has spoken on 19 earnings calls and 1 other investor event across 1 company, most recently for Warby Parker Inc. on November 5, 2026. Warby Parker Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Warby Parker Inc. includes Neil Blumenthal (CEO and Board Member), Adrian Mitchell (CFO and Chief Accounting Officer), Steven Miller (CFO) and 7 others.
“Throughout 2026, we've made significant investments in our most important long-term growth initiatives while continuing to execute against the core business.”
“Well, I'll speak to the dynamics we're seeing in e-commerce and the investments we're making to support a successful launch of intelligent eyewear and drive customer growth in the back half of this year.”
“Yeah, so we've really been kind of describing it to our team as we're entering Act 3 as a business. And so Act 1 was around when we launched, when we pioneered the direct consumer made on the internet model.”
“Our second strategic priority in 2026 is organizational readiness for our intelligent eyewear launch later this year. This is a massive cross-functional effort.”
“Thank you for joining us today to discuss our fourth quarter and fiscal 2025 results and our outlook for 2026. 2025 was an eventful year and one that we're proud of.”
2025-10-01–present
2025-10-01–present
2009-01-01–present
Last confirmed April 28, 2026
Start not stated–present
Last confirmed April 28, 2026
WRBY
Medical Instruments & Supplies · Healthcare
CEO, Chief Accounting Officer, CFO, Board Member
2009-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $575,000 | $8,997,680 |
| 2024 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $555,000 | $1,476,151 |
| 2023 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $525,000 | $907,144 |
| 2022 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $500,000 | $699,700 |
| 2021 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $450,000 | $103,599,384 |
| 2020 | Warby Parker Inc. (WRBY) | Co-CEO and Director | $425,000 | $736,025 |